Camurus AB is a Swedish biopharmaceutical company based in Lund, specializing in the development of innovative treatment solutions for severe and chronic diseases. The company is focused on creating long-acting therapies that aim to improve the quality of life for patients. With a science-led approach to drug development, Camurus engages in extensive research to advance its product pipeline and address unmet medical needs.
In addition to its core activities, Camurus actively participates in healthcare conferences and seminars, contributing to discussions on advancements in the pharmaceutical industry. The company is committed to corporate governance and maintains regular communication with shareholders through updates and news releases. This engagement includes involvement in annual general meetings, ensuring transparency and accountability in its operations.